Eric Dwayne Hawkins

Title: Eric Dwayne Hawkins: Innovator in Pharmaceutical Compositions

Introduction

Eric Dwayne Hawkins is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of insulin compositions. His work aims to enhance the treatment of diabetes through innovative combinations of medications.

Latest Patents

Hawkins holds a patent for "Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicylic acid and paracetamol." This invention relates to pharmaceutical insulin compositions that include insulin, a preservative, and at least one agent from a specified group. The compositions are designed to treat diabetes effectively.

Career Highlights

Eric Dwayne Hawkins is associated with Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation in healthcare. His work at Eli Lilly has allowed him to focus on developing advanced therapeutic solutions for patients.

Collaborations

Hawkins has collaborated with notable colleagues, including John Michael Beals and Anthony Shane Ransdell. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Eric Dwayne Hawkins is a prominent figure in the pharmaceutical industry, recognized for his innovative contributions to diabetes treatment. His work continues to impact the field positively, showcasing the importance of collaboration and creativity in medical advancements.